3.70MMarket Cap-0.74P/E (TTM)
0.780High0.740Low39.60KVolume0.755Open0.760Pre Close30.05KTurnover0.85%Turnover RatioLossP/E (Static)4.94MShares3.50052wk High-0.48P/B3.50MFloat Cap0.63152wk Low--Dividend TTM4.67MShs Float246.000Historical High--Div YieldTTM5.25%Amplitude0.500Historical Low0.758Avg Price1Lot Size
NAYA Biosciences Stock Forum
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
SARASOTA, Fla. and MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility, today ...
No comment yet